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749REPLY: : Extracellular Volume and
Cardiac Mechanics: Have We Found a
Missing Puzzle Piece?We thank Drs. Tadic and Cuspidi for their interest in
our study (1) evaluating the relationship between
myocardial ﬁbrosis and mechanics in hypertensive
heart disease. We agree with the writers that multiple
factors could affect myocardial ﬁbrosis and extracel-
lular volume (ECV), which require further study in a
larger cohort of patients. We did not speciﬁcally
exclude patients with diabetes, obesity, or metabolic
syndrome from the study. There were 4 subjects with
diabetes in the hypertension (HTN) non–left ventric-
ular hypertrophy (LVH) group and 6 in the HTN LVH
group. There was no signiﬁcant difference in ECV
between patients with diabetes and those without
diabetes in our study. Glucose and lipid data were not
available. With regard to obesity, there was no dif-
ference in body mass index between the groups, and
there was no signiﬁcant correlation between body
mass index and either ECV or native T1. Thus, within
the context of our study, these factors do not explain
the differences in ECV and native T1 observed be-
tween the groups.
To avoid confounding conditions that could
contribute to myocardial ﬁbrosis, we excluded sub-
jects with left ventricular (LV) ejection fraction <45%.
In our study, there was no difference in LV ejection
fraction among the 3 groups (63.2  5.1%, 65.8  8.5%,
and 64.5  7.4%) and no correlation between LV
ejection fraction and ECV or native T1.
Regarding systolic blood pressure (SBP), concen-
tricity (as deﬁned by the ratio of LV mass to end-
diastolic volume), and left ventricular mass index
(LVMI), we chose to focus on LVMI given that LVH
reﬂects the cumulative effect of high blood pressure
on ventricular remodeling, rather than a single–time
point assessment of blood pressure. From the clinical
data, it is difﬁcult to ascertain important factors, such
as the duration of HTN, adequacy of blood pressure
control, and the speciﬁc duration of therapy with
each antihypertensive medication, whereas LV mass
could be directly measured from the cardiac magnetic
resonance data. This being said, as expected, there
were signiﬁcant correlations of SBP with ECV and
native T1 (R ¼ 0.29 and R ¼ 0.36, respectively) andbetween concentricity and ECV and native T1
(R ¼ 0.34 and R ¼ 0.34, respectively). However, the
correlations between LVMI and SBP and LVMI and
concentricity were signiﬁcantly higher (R ¼ 0.69 and
R ¼ 0.74, respectively), reﬂecting the high degree of
colinearity among LV mass, SBP, and concentricity.
Finally, it is known that renin-angiotensin-
aldosterone system inhibition reduces LVH in re-
search studies, presumably by an effect on both blood
pressure and myocardial ﬁbrosis. In our study, 51% of
the HTN non-LVH patients and 85% of the HTN LVH
patients were on blood pressure regimens that
included either angiotensin-converting enzyme in-
hibitors or angiotensin receptor blockers. There was
no difference in ECV or native T1 between patients
with or without renin-angiotensin-aldosterone inhi-
bition. Again, multiple factors including variations in
the antihypertensive regimens, duration of therapy,
and adequacy of blood pressure control confound this
assessment.
We believe that further study of myocardial ﬁbrosis
and mechanical function in patients with hyperten-
sive heart disease is warranted and could have
important implications for predicting risk in this pa-
tient population and for developing novel antiﬁbrotic
therapies for LVH and heart failure with preserved
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